BIO communications VP
Executive Summary
The Biotechnology Industry Organization names Jeffrey Joseph VP-communications effective Sept. 6. The position has been vacant since Dan Eramian joined Cell Therapeutics earlier this year (1"The Pink Sheet" March 6, 2006, In Brief). Joseph was previously VP-communications & strategic relation at the Consumer Electronics Association and spent 11 years at Ogilvy Public Relations Worldwide...
You may also be interested in...
BIO VP moves to Cell Therapeutics
Former Biotechnology Industry Organization VP-Communications Dan Eramian will join Cell Therapeutics as exec VP-corporate communications, the company announced Feb 28. Prior to joining BIO, Eramian worked in public affairs for the Department of Justice...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.